Pediatric Infections | Varsity Tutors

SECTION 1

Historical Context & Motivation

Throughout most of human history, infectious diseases were the leading cause of childhood mortality, claiming millions of lives before the age of five. The evolution of pediatric infectious disease as a discipline is inseparable from the broader advances in microbiology, immunology, and vaccinology that transformed modern medicine. Understanding this historical trajectory illuminates why certain pathogens disproportionately affect children and how our current management strategies emerged from decades of clinical observation and scientific inquiry.

1796

Jenner's Smallpox Vaccine

Edward Jenner demonstrated that inoculation with cowpox conferred immunity to smallpox, establishing the foundational principle of vaccination and paving the way for the prevention of numerous pediatric infections.

1928

Discovery of Penicillin

Alexander Fleming's discovery of penicillin ushered in the antibiotic era, dramatically reducing mortality from bacterial infections such as pneumonia, meningitis, and septicemia in children.

1955

Salk Polio Vaccine

The inactivated poliovirus vaccine developed by Jonas Salk virtually eliminated paralytic poliomyelitis in vaccinated populations, a disease that had terrorized families and filled pediatric wards with iron lungs.

1987

Hib Conjugate Vaccine

The Haemophilus influenzae type b conjugate vaccine reduced invasive Hib disease—including meningitis and epiglottitis—by more than 99% in immunized populations, representing one of the greatest triumphs of pediatric vaccinology.

2006

Rotavirus Vaccine Introduction

Licensure of the rotavirus vaccine dramatically decreased hospitalizations for severe gastroenteritis, the most common cause of dehydrating diarrhea in infants worldwide.

Despite these landmark achievements, pediatric infections continue to present significant clinical challenges. Neonates and young infants remain uniquely vulnerable due to their immature immune systems, and the rise of antimicrobial resistance threatens to reverse decades of progress. Furthermore, emerging pathogens and shifting epidemiology demand that clinicians maintain a thorough understanding of the presentation, diagnosis, and management of common and serious infections in childhood. The central question this lesson addresses is: how does a clinician systematically approach the febrile child to distinguish self-limited viral illness from life-threatening bacterial infection requiring urgent intervention?

SECTION 2

Core Principles of Pediatric Infectious Disease

The approach to pediatric infections rests on several foundational principles that distinguish the pediatric patient from the adult. A child's immune system undergoes maturation throughout the first several years of life, and this developmental trajectory determines susceptibility to specific pathogens at different ages. Additionally, the clinical presentation of infection in neonates and young infants is often nonspecific—manifesting as poor feeding, irritability, or temperature instability rather than the localizing signs seen in older children and adults. Mastery of these principles allows the clinician to stratify risk, order appropriate workup, and initiate targeted therapy.

Age-Dependent Susceptibility

Neonates (0–28 days) are vulnerable to Group B Streptococcus, E. coli, and Listeria monocytogenes. Toddlers face increasing exposure to respiratory and gastrointestinal pathogens through daycare attendance. School-age children and adolescents encounter different organisms reflecting their social environments.

Immune Immaturity

Transplacental maternal IgG provides passive immunity during the first 3–6 months. After this wanes, the infant enters a physiologic nadir of immunoglobulin levels. The complement system and opsonization pathways are also relatively deficient in young infants, impairing clearance of encapsulated organisms.

Fever as a Cardinal Sign

Fever (rectal temperature ≥ 38.0°C) in an infant under 60 days of age warrants a full sepsis workup. The Rochester, Philadelphia, and Boston criteria help stratify these infants into low- and high-risk categories for serious bacterial infection.

Vaccination Status Matters

The child's immunization history is critical in narrowing the differential diagnosis. An unvaccinated child presenting with respiratory distress and inspiratory stridor may have epiglottitis due to Hib, whereas this diagnosis is exceedingly rare in fully immunized children.

Source-Oriented Approach

Organizing the differential by anatomic site—upper respiratory, lower respiratory, CNS, GI, and skin/soft tissue—allows for systematic evaluation and ensures that no critical diagnosis is overlooked.

✦ KEY TAKEAWAY

Think of a child's developing immune system like a city building its defenses. Newborns start with borrowed walls (maternal antibodies) that gradually crumble over the first 6 months. Vaccinations act as permanent fortifications built at scheduled intervals, and until those fortifications are complete, the child remains vulnerable at predictable gates. Knowing which gates are open at each age tells you which invaders can breach the defenses—this is the essence of age-based pathogen risk stratification.

SECTION 3

Visual Overview: Age-Based Pathogen Map

This diagram maps common pathogens to age groups, illustrating how age-dependent immune maturation determines susceptibility. Note how neonatal pathogens (GBS, E. coli, Listeria) reflect vertical transmission, while older children encounter community-acquired organisms (GAS, Mycoplasma). Empiric therapy recommendations at the bottom reflect this age-based pathogen profile.

The diagram above serves as a clinical roadmap. When evaluating a febrile infant, the first question should always be "How old is this child?" A febrile 10-day-old requires a markedly different workup and empiric coverage than a febrile 5-year-old. In the neonatal period, the combination of ampicillin (covering Listeria and Enterococcus) with an aminoglycoside (providing synergistic gram-negative coverage) represents the standard empiric regimen. Acyclovir should be added when clinical features raise concern for neonatal herpes simplex virus infection, including vesicular skin lesions, seizures, hepatitis, or maternal history of genital herpes. As children age beyond 3 months, the predominant pathogens shift toward Streptococcus pneumoniae, non-typeable Haemophilus influenzae, and Staphylococcus aureus, and empiric therapy transitions accordingly to third-generation cephalosporins.

SECTION 4

Pathophysiology & Diagnostic Approach

The Febrile Infant Algorithm

The systematic evaluation of a febrile infant represents one of the most critical clinical algorithms in pediatrics. The risk of serious bacterial infection (SBI)—defined as bacteremia, urinary tract infection, or bacterial meningitis—varies dramatically by age. In neonates under 28 days, the prevalence of SBI among those presenting with fever ranges from 8% to 12%. Between 29 and 60 days, this decreases to approximately 5–8%, and by 61 to 90 days it falls further to around 3–5%. These prevalence figures drive the aggressiveness of the workup.

Workup Components by Age

Recommended workup components for the febrile infant stratified by age

Component	0–28 days	29–60 days	61–90 days
CBC with differential	Always	Always	Consider
Blood culture	Always	Always	If ill-appearing
Urinalysis + culture	Always (catheterized)	Always (catheterized)	Always
Lumbar puncture	Always	Strongly consider	If clinical concern
CRP / Procalcitonin	Recommended	Recommended	Helpful for risk stratification
Empiric antibiotics	Always (admit)	If high-risk or pending LP	If high-risk
Disposition	Admit	Admit if high-risk; low-risk may observe	Outpatient if low-risk with follow-up

Inflammatory Markers in Risk Stratification

Modern risk stratification tools increasingly rely on procalcitonin (PCT) as a biomarker for bacterial infection. PCT rises within 2–4 hours of bacterial infection onset and peaks at 6–8 hours, making it superior to C-reactive protein (CRP) for early detection. A procalcitonin level < 0.5 ng/mL carries a high negative predictive value for SBI, and the Step-by-Step approach to febrile infants 29–90 days integrates PCT along with clinical appearance, absolute neutrophil count (ANC > 4,000/μL as a risk factor), and urinalysis to categorize infants into risk tiers. The WBC count alone has relatively poor sensitivity and specificity for SBI, which is why multi-parameter scoring systems have supplanted older single-variable protocols.

⚠️ HIGH-YIELD BOARD POINT

Any neonate (≤ 28 days) with a fever ≥ 38.0°C requires full sepsis workup (CBC, blood culture, catheterized UA/culture, lumbar puncture), empiric antibiotics (ampicillin + gentamicin), and hospital admission—regardless of how well the infant appears. This is a non-negotiable standard of care.

SECTION 5

Classification of Major Pediatric Infections by System

A systems-based approach to pediatric infections allows the clinician to organize a broad differential and recognize the classic presentation patterns that appear on board examinations and in clinical practice. The following sections address the highest-yield infections organized by anatomic site, emphasizing presentation, etiology, and management.

Systems-based overview of major pediatric infections. Each box represents an organ system with the most commonly tested pathogens and clinical syndromes. The bottom box highlights the classic childhood exanthems that are perennial board favorites.

High-Yield Respiratory Infections

Croup (laryngotracheobronchitis) is most commonly caused by parainfluenza virus and classically presents in children aged 6 months to 3 years with a barking (seal-like) cough, inspiratory stridor, and hoarseness. The characteristic steeple sign on anteroposterior neck radiograph reflects subglottic narrowing. Management depends on severity: mild cases respond to a single dose of oral dexamethasone (0.6 mg/kg), while moderate-to-severe cases additionally receive nebulized racemic epinephrine. It is essential to distinguish croup from epiglottitis (now rare due to Hib vaccination), which presents with the 4 D's—dysphagia, drooling, distress, and dysphonia—along with a toxic-appearing child sitting in the tripod position. The lateral neck film shows the thumbprint sign (swollen epiglottis), and the priority is airway management rather than imaging.

High-Yield CNS Infections

Bacterial meningitis beyond the neonatal period is most commonly caused by Streptococcus pneumoniae and Neisseria meningitidis. Classic CSF findings include elevated WBC with neutrophilic predominance, elevated protein, and low glucose (CSF-to-serum glucose ratio < 0.4). Empiric therapy in children older than 1 month is ceftriaxone plus vancomycin, with dexamethasone administered before or concurrent with the first dose of antibiotics to reduce the risk of sensorineural hearing loss (particularly with Hib meningitis, though S. pneumoniae data also support this practice). Neonatal HSV encephalitis is a critical mimicker—always consider acyclovir in any neonate with seizures, CSF pleocytosis, or skin vesicles, as delay in treatment dramatically worsens outcomes.

SECTION 6

Worked Clinical Vignette

A 16-day-old previously healthy full-term male is brought to the emergency department by his parents for fever of 38.5°C (rectal) noted at home 3 hours ago. He has been feeding poorly for the past 12 hours. He was born via spontaneous vaginal delivery; the mother was GBS-positive and received adequate intrapartum prophylaxis. On exam, the infant appears lethargic with mottled skin and a capillary refill time of 4 seconds. No focal findings are identified.

Approach to the Febrile Neonate

Step 1 — Recognize the High-Risk ScenarioThis is a 16-day-old neonate with fever ≥ 38.0°C. Regardless of clinical appearance, any febrile infant ≤ 28 days old requires a complete sepsis evaluation. The lethargy, mottled skin, and prolonged capillary refill further raise concern for hemodynamic compromise consistent with sepsis.

Classification: Ill-appearing febrile neonate — highest risk category

Step 2 — Initiate Full Sepsis WorkupOrder CBC with differential, blood culture, comprehensive metabolic panel, urinalysis with culture (via catheterization), and lumbar puncture (CSF cell count, glucose, protein, culture, and HSV PCR). Additionally, obtain procalcitonin and CRP for prognostic value. If there are any respiratory symptoms, obtain a chest radiograph. Given the age and ill appearance, also send CSF HSV PCR and consider enteroviral PCR, as these viruses can produce neonatal sepsis-like presentations.

Full sepsis workup obtained: CBC, BMP, blood culture, catheterized UA/UCx, LP (cell count, glucose, protein, Gram stain, culture, HSV PCR)

Step 3 — Start Empiric Therapy ImmediatelyDo not wait for results before initiating treatment in an ill-appearing neonate. The standard empiric regimen is ampicillin + gentamicin. Ampicillin covers GBS, Listeria, and Enterococcus; gentamicin provides synergistic gram-negative coverage and augments GBS killing. Because of the ill appearance and possibility of meningitis, some centers would substitute cefotaxime for gentamicin to ensure adequate CSF penetration, while still maintaining ampicillin for Listeria coverage. Add acyclovir (60 mg/kg/day divided every 8 hours) given the ill appearance, pending HSV PCR results.

Empiric therapy: Ampicillin + Gentamicin (or Cefotaxime) + Acyclovir

Step 4 — Address Hemodynamic InstabilityThe mottled skin and prolonged capillary refill suggest poor perfusion. Initiate IV fluid resuscitation with a 20 mL/kg normal saline bolus and reassess. Neonates in septic shock may require repeated boluses and potentially vasoactive support (epinephrine is first-line in pediatric septic shock per Surviving Sepsis guidelines). Monitor urine output, mental status, and capillary refill as resuscitation endpoints.

20 mL/kg NS bolus administered; reassess perfusion after each bolus

Step 5 — Interpret Results and Narrow TherapySuppose the blood culture grows GBS at 18 hours and the CSF culture is negative. Narrow antibiotics to IV penicillin G or ampicillin for a total course of 10 days for bacteremia without meningitis. If CSF had been positive, the treatment duration would extend to a minimum of 14–21 days. Discontinue acyclovir if HSV PCR is negative at 48–72 hours and clinical course is consistent with bacterial infection. Despite adequate maternal GBS prophylaxis, late-onset GBS disease (7–90 days) can still occur through horizontal acquisition and is not prevented by intrapartum antibiotics.

Final diagnosis: Late-onset GBS bacteremia. Treatment: IV penicillin G × 10 days.

SECTION 7

Distinguishing Key Pediatric Infections

Board examinations frequently test the ability to differentiate conditions that share overlapping features. The following table compares commonly confused pediatric infections that present with fever and rash—a classic testing theme.

Comparison of major pediatric exanthems and fever-rash syndromes

Condition	Etiology	Classic Rash Description	Key Distinguishing Feature
Measles	Paramyxovirus (Morbillivirus)	Maculopapular, starts at face/hairline, spreads cephalocaudally	Koplik spots (bluish-white spots on buccal mucosa); 3 C's (cough, coryza, conjunctivitis)
Rubella	Rubella virus (Togavirus)	Fine pink maculopapular, starts on face, spreads downward	Postauricular and suboccipital lymphadenopathy; Forchheimer spots on palate
Roseola (Exanthem Subitum)	HHV-6	Diffuse maculopapular rash appears as fever resolves	High fever (often > 40°C) × 3–5 days preceding rash; child appears well when rash appears
Erythema Infectiosum	Parvovirus B19	"Slapped cheek" → lacy reticular rash on trunk/extremities	Aplastic crisis in sickle cell disease; hydrops fetalis risk in pregnancy
Scarlet Fever	Group A Streptococcus (erythrogenic toxin)	Diffuse sandpaper-texture erythema, sparing palms/soles	Strawberry tongue; Pastia lines (linear petechiae in skin folds); desquamation in recovery
Kawasaki Disease	Unknown (likely infectious trigger)	Polymorphous, non-vesicular, often perineal desquamation	Fever ≥ 5 days + 4/5 criteria; coronary artery aneurysm risk; treat with IVIG + aspirin

💡 CLINICAL PEARL

Think of the childhood exanthems like a detective lineup—each suspect has a unique set of identifying marks. Measles brings its Koplik spots as an early calling card; scarlet fever leaves its fingerprint as Pastia lines in the creases; Kawasaki disease is the great imitator that must be identified before it attacks the coronary arteries. The key to board questions is to look for the one pathognomonic feature that distinguishes each condition, then confirm with the supporting clinical context.

SECTION 8

Connections to Advanced Pediatric Infectious Disease

The foundational knowledge of common pediatric infections serves as a gateway to more complex clinical scenarios that appear on advanced board examinations and in clinical practice. Understanding how immunocompromised states, congenital infections, and antimicrobial resistance alter the landscape of pediatric infectious disease is essential for the aspiring clinician.

Bridging core pediatric infections to advanced clinical topics

Core Concept	Advanced Extension
Febrile infant workup and empiric therapy	Febrile neutropenia protocols in oncology patients: broader coverage with anti-pseudomonal agents (cefepime, piperacillin-tazobactam); consideration of fungal coverage after 4–7 days of persistent fever
Neonatal GBS/E. coli meningitis	TORCH infections (Toxoplasma, Other, Rubella, CMV, HSV): congenital infections presenting with microcephaly, intracranial calcifications, chorioretinitis, hepatosplenomegaly, and hearing loss
Community-acquired MRSA skin abscesses	Antimicrobial stewardship: understanding PVL-positive CA-MRSA strains, appropriate use of TMP-SMX vs. clindamycin, and the role of I&D alone for uncomplicated abscesses
Routine childhood vaccination schedule	Vaccine-preventable disease outbreaks in under-immunized populations; catch-up schedules; special immunization considerations for immunocompromised hosts (no live vaccines)
Kawasaki disease recognition	Incomplete Kawasaki disease: fever ≥ 5 days with fewer than 4 classic criteria; role of echocardiography and inflammatory markers (CRP, ESR, albumin, ALT, platelets) in diagnosis; MIS-C as a differential

One of the most important emerging topics is Multisystem Inflammatory Syndrome in Children (MIS-C), a post-infectious hyperinflammatory condition associated with SARS-CoV-2 that shares features with Kawasaki disease and toxic shock syndrome. MIS-C typically presents 2–6 weeks after COVID-19 exposure with persistent fever, multiorgan dysfunction (cardiac, GI, hematologic), and markedly elevated inflammatory markers. Unlike classic Kawasaki disease, MIS-C tends to affect older children and adolescents and is more frequently associated with myocardial dysfunction and shock. Treatment includes IVIG, corticosteroids, and supportive care. Recognizing the overlap and distinctions between MIS-C, Kawasaki disease, and bacterial sepsis represents a frontier of pediatric infectious disease that will continue to evolve.

🔭 LOOKING AHEAD

As you advance in your studies, the principles learned here—age-based risk stratification, systematic workup algorithms, and pattern recognition of classic presentations—will serve as the scaffold upon which you build expertise in immunodeficiency evaluations, transplant infectious disease, and global pediatric infectious disease. The approach never changes—only the complexity of the host and the pathogen.

SECTION 9

Practice Problems

PROBLEM 1 — CONCEPTUAL

A 2-month-old infant presents with a rectal temperature of 38.3°C. The parents report the infant has been feeding well and is interactive. Why does this infant require a more extensive workup than a febrile 2-year-old with similar vital signs and clinical appearance?

PROBLEM 2 — BASIC CALCULATION

A 21-day-old, 3.5 kg neonate is started on empiric ampicillin (150 mg/kg/day divided every 8 hours) and gentamicin (4 mg/kg/dose every 24 hours) for suspected neonatal sepsis. Additionally, acyclovir (60 mg/kg/day divided every 8 hours) is added. Calculate the dose of each medication per administration.

PROBLEM 3 — INTERMEDIATE

A 3-year-old unvaccinated child presents with acute onset of high fever, drooling, muffled voice, and refusal to lie down, preferring to sit leaning forward. Inspiratory stridor is noted. The parents initially thought this was croup. Compare and contrast this presentation with croup and identify the most likely diagnosis, causative organism, and immediate management priorities.

PROBLEM 4 — APPLIED

A 4-year-old boy with sickle cell disease presents with fever (39.2°C), left leg pain, and refusal to bear weight for 3 days. Radiographs show periosteal elevation of the left femur. ESR is 65 mm/hr and CRP is 8.2 mg/dL. Blood cultures are pending. What is the most likely diagnosis, what organism must be specifically considered in this clinical context beyond the most common cause, and how does the management differ from a child without sickle cell disease?

PROBLEM 5 — CRITICAL THINKING

A 7-year-old girl presents with 6 days of persistent high fever (up to 40.5°C), bilateral non-exudative conjunctivitis, erythematous cracked lips, a polymorphous truncal rash, and swollen hands. Laboratory findings include WBC 18,000/μL, platelets 480,000/μL, ESR 72 mm/hr, CRP 12.5 mg/dL, albumin 2.8 g/dL, and ALT 85 U/L. Echocardiogram reveals mild coronary artery dilation (z-score 2.8). Her SARS-CoV-2 antibody is positive though PCR is negative. The team debates between Kawasaki disease and MIS-C. Discuss the overlapping and distinguishing features, the diagnostic approach, and the management implications of each diagnosis.

SUMMARY

Pediatric Infections — Key Concepts Review

Pediatric infections demand a systematic approach anchored in age-based pathogen risk stratification. Neonates (0–28 days) are susceptible to GBS, E. coli, Listeria, and HSV, requiring empiric therapy with ampicillin + gentamicin ± acyclovir. As children age, the pathogen profile shifts toward S. pneumoniae, S. aureus, and GAS, with empiric regimens transitioning to third-generation cephalosporins ± vancomycin. The febrile infant algorithm mandates full sepsis workup and admission for neonates ≤ 28 days, with graded evaluation and risk stratification tools (Rochester, Philadelphia, Boston criteria, and newer PCT-based protocols) guiding management in the 29–90 day age group.

Recognition of classic childhood exanthems—measles (Koplik spots), roseola (fever-then-rash pattern), erythema infectiosum (slapped cheek), and scarlet fever (sandpaper rash, strawberry tongue)—is essential for board examinations. Kawasaki disease (fever ≥ 5 days + 4/5 mucocutaneous criteria, treated with IVIG + aspirin) and MIS-C represent critical diagnoses where timely recognition prevents devastating cardiac complications. The approach to upper airway emergencies (croup vs. epiglottitis), bacterial meningitis (CSF analysis, empiric vancomycin + ceftriaxone + dexamethasone), and musculoskeletal infections (S. aureus predominance, Salmonella in sickle cell disease) rounds out the core knowledge required for clinical competence and board success in pediatric infectious disease.